$TSBK

Timberland Bancorp, Inc. (TSBK) FY26 EPS Up 8%; Dividend Raised 3%

Timberland Bancorp (TSBK) reported FY26 net income of $31.17M, up 7% YoY, with EPS of $3.96, up 8%. Q4 EPS rose 6% to $1.04. The company increased its quarterly dividend by 3% to $0.31. Key metrics improved, including net interest margin (3.96%) and returns on assets and equity.

Original reporting
Published Oct 30, 2026, 12:24 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 30, 2026, 12:32 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Timberland Bancorp, Inc. (TSBK) FY26 EPS Up 8%; Dividend Raised 3% — source image
Decision brief

The 30-second read

$TSBKBullishMed
01

Why it matters

For traders, the actionable elements are the reported EPS/NIM/ROA/ROE figures and the dividend increase with a stated payable date, which can influence both valuation and income-demand positioning.

02

Market read

Company-specific earnings and capital-return update for a regional bank, with margin expansion and higher dividend likely supportive for near-term sentiment.

03

What to watch

Traders may want to verify whether the NIM expansion is driven by sustainable asset mix and funding costs, and whether credit metrics worsened even as profitability rose.

Relevance 6/10Novelty 6/10Timing: immediately after the FY26 results and dividend declaration (published pre-market/early session)

Background

The piece summarizes Timberland Bancorp’s FY26 and Q4 profitability metrics and a board decision to raise the quarterly dividend.

Company-level read

Ticker impact

$TSBKBullishMedium confidence
Context

Timberland Bancorp reported FY26 EPS of $3.96 (+8% YoY) and raised the quarterly dividend 3% to $0.31, payable Nov. 27, 2026.

Expected impact

Likely upward bias as the market prices in stronger margin-driven earnings and a higher cash yield.

Evidence & confidence

The article provides specific, company-attributable financial results and a dividend increase, which typically supports sentiment for regional banks, though it does not include guidance or credit-quality details.

Market effects

Adds another data point that regional banks can sustain margin expansion (NIM) and translate it into higher ROA/ROE.

Supports sentiment toward US regional banking names with similar balance-sheet and yield dynamics.

Low; this is company-specific and not tied to global macro policy.

Counterpoint

Without disclosed credit deterioration or loan-growth quality, the market may discount the EPS and NIM gains as potentially temporary.

Key entities

  • Timberland Bancorp, Inc.

    Regional bank reporting FY26 EPS of $3.96 (+8% YoY) and raising the quarterly dividend 3% to $0.31.

Related articles

$TSBKMed

TIMBERLAND BANCORP INC (TSBK): Results of Operations and Financial Condition

TIMBERLAND BANCORP INC (TSBK) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Contact: Dean J. Brydon, CEO Jonathan A. Fischer, President & COO Marci A. Basich, CFO (360) 533-4747 www.timberlandbank.com Timberland Bancorp Reports Third Fiscal Quarter Net Income of $7.72 Million • Quarterly EPS Increases 9% to $0.98 from $0.90 for the Comparabl

$BMYMedAI 9/10

Bristol Myers Squibb Q3 Earnings Call Highlights

Bristol Myers Squibb (BMY) reported Q3 earnings, with eight drugs generating over $1B annually. QVANTIG revenue rose 28% to $334M, while OPDIVO fell 6% to $2.4B. BREYANZI and CAMZYOS saw significant growth. The company highlighted FDA approvals and upcoming data for new treatments. BMY plans a $2.3B Houston manufacturing campus and remains active in business development.

$TRSMed

What TriMas (TRS) Said on Its Q3 Earnings Call

TriMas (TRS) reported Q3 earnings with Packaging operating profit up 11.9% to $20.4M, but Specialty Products saw profit decline. The company expects Packaging margins to reach 14% and full-year sales growth of 4-5%. Specialty Products faces production challenges, with margins expected to improve sequentially. TriMas reaffirmed its adjusted earnings outlook of $1.60-$1.70 per share and raised its sales growth outlook to 4-6%.